GJA1 and prostate cancer: Emerging evidence has confirmed that Cx43 can act as a tumor suppressor in gastric cancer, melanoma, pancreatic cancer, lung cancer, chronic B-cell leukemia, prostate cancer, breast cancer, and thyroid cancer [9,15,16,17,18,20,21,22,23].